Cellebrite Completes Acquisition of Corellium, Extending the Industry’s Most Advanced AI-Powered Digital Investigation Platform
Cellebrite DI Ltd. - Ordinary Shares (CLBT)
Company Research
Source: GlobeNewswire
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced it has substantially expanded its capabilities through the acquisition of Corellium, a leader in Arm-based virtualization software. The addition of Corellium's technology and world-class technical talent further strengthens Cellebrite's market and technology leadership. This combination creates the industry's most complete digital investigation portfolio spanning physical device access, virtual device testing and real-time intelligence. The technology enables investigators, security researchers and intelligence professionals to work without physical device constraints while dramatically accelerating time to evidence and threat detection. The acquisition significantly expands the value of Cellebrite's AI-powered capabilities for a wide variety of cus
Show less
Read more
Impact Snapshot
Event Time:
CLBT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLBT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLBT alerts
High impacting Cellebrite DI Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
CLBT
News
- Cellebrite DI (NASDAQ:CLBT) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- How Do Cellebrite DI's New Partnerships Impact Its Value After a 19.8% Price Jump? [Yahoo! Finance]Yahoo! Finance
- Cellebrite (CLBT) Jumps 20.7% on Stellar Q3 [Yahoo! Finance]Yahoo! Finance
- Cellebrite DI (NASDAQ:CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $23.00 to $24.00. They now have an "overweight" rating on the stock.MarketBeat
- Cellebrite DI (NASDAQ:CLBT) had its price target raised by analysts at Lake Street Capital from $22.00 to $23.00. They now have a "buy" rating on the stock.MarketBeat
CLBT
Earnings
- 11/12/25 - Beat
CLBT
Sec Filings
- 12/4/25 - Form 144
- 12/2/25 - Form 6-K
- 11/24/25 - Form 144
- CLBT's page on the SEC website